VKTX Stock Gives Back Buyout Speculation-Spurred Gains, Investors Continue To Await Key Obesity Trial Topline Data
For VKTX investors, the main focus is the expected VANQUISH trial topline data readout in 2027.
For VKTX investors, the main focus is the expected VANQUISH trial topline data readout in 2027.